Vision

Empowering Digital Transformation with Advanced Production Tools to Make the World Healthier and Better.

ABOUT MEGAROBO


MegaRobo is a pioneering science and technology innovator specializing in artificial intelligence and automation. We are dedicated to delivering next-generation digital productivity tools for frontiers industries encompassing life sciences, healthcare, applied chemistry, and advanced manufacturing. Through intelligent software-hardware ecosystems, we propel industries toward a future defined by efficiency, precision, and sustainability.


By deeply integrating core technologies including artificial intelligence and robotic automation with industry-specific applications, MegaRobo has significantly empowered critical fields: drug development, clinical diagnostics, fundamental research and synthetic biology. Our solutions are facilitating the digital-intelligent leap in scientific research and industrial processes.


Building upon our profound expertise in life sciences, MegaRobo is strategically extending its technological leadership and product innovation into emerging sectors such as advanced materials, new energy, and intelligent agriculture. We enable global partners to architect intelligent organizations, transcend technological barriers, and redefine operational paradigms. As a catalyst of industrial evolution, we stand committed to being the premier collaborator in driving paradigm-shifting upgrades and sustainable value creation.


Our Team

  • 900+

    Employees

  • 50%+

    R&D personnel

  • 430+

    Issued Patents

Milestone

2016

June
Founded in Beijing
Pioneer in life sciences automation solutions market

2017

June
Angel round

2018

November
Suzhou delivery center started operation

2019

April
Series A/A+ rounds led by BOSCH
December
MagaRobo’s life sciences lab in operation
Entered into life sciences research services market

2020

August
Developed world’s first high-throughput sample processing and RNA extraction instruments for Covid PCR test
November
Shenzhen delivery center started operation

2021

May
Series B1/B2/B3 rounds led by Sinovation Ventures/MPCi/WuXi AppTec
August
MegaLab phase I by MEGAROBO established in Beijing
September
Intelligent genetic engineering lab established in Shanghai
Entered into cell and gene therapy solution services market
 
 

2022

April
Series C round led by Goldman Sachs, Asia Investment Capital
June
Head offices in Singapore, US and Japan established
Global expansion initiated

2023

May
MegaLab 2.0 construction commenced
December
MegaRobo officially launches SAP system and enters digitalization

2024

January
Chemlex, a subsidiary of MegaRobo, has completed Series A financing

QUALIFICATIONS AND HONORS


ISO13485(BEIJING)

ISO13485(SUZHOU)

ISO 9001

EU DOC Certification

UDEM Certification

UKCA Certification

National High-Tech Enterprise(BEIJING)

National High-Tech Enterprise(SUZHOU)

National High-Tech Enterprise(SHENZHEN)

Beijing Technologically Advanced ‘Little Giant’ Enterprises

Jiangsu Specialized and Sophisticated SMEs

Shenzhen Specialized and Sophisticated SMEs

Deloitte China Technology Fast 50

MIT Technology Review - 50 Smartest Companies in China 2021

Deloitte China Rising Star 2020

DNA Paris Design Awards 2022

Spark Design Awards 2021

IDA Design Awards 2021

Contemporary Good Design Award 2021